Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis
S. Takeo et al., Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis, CANC GENET, 130(2), 2001, pp. 127-132
To identify amplified oncogenes involved in hepatocellular carcinomas (HCC)
, we applied a genomic DNA microarray spotted with 57 oncogenes to 20 HCCs.
Aberrations in DNA copy number also were analyzed by comparative genomic h
ybridization (CGH) using an aliquot of DNA samples. In 5 of 20 HCCs, only 6
oncogenes (CCND1, FGF3/FGF4, SAS/CDK4, TERC, MET, and MYC) were amplified,
whereas in the remaining 15 tumors no oncogenes were amplified. A comparis
on of DNA microarray and conventional CGH analyses showed that, although 5
of 6 amplified oncogenes shown by microarray were located in chromosomal re
gions shown by CGH to have increased DNA copy numbers, not all genes locate
d in such chromosomal regions were affected. One of the amplified oncogenes
(SAS/CDK4) was found in a chromosomal region that was undetected by CGH. W
e, therefore, conclude that amplification of the oncogenes examined in this
series is not directly implicated in hepatocellular carcinogenesis. (C) 20
01 Elsevier Science Inc. All rights reserved.